BABA
Alibaba Group Holding Limited
BABA offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
HRB
H&R Block, Inc.
HRB has the edge over BABA overall, supported by stronger fundamentals and stronger valuation.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
HRB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Healthy |
HRB's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
HRB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.3x | $50.73 | — |
| Cheap | 8.8x | $47.55 | -6.3% |
| Current | 9.4x | $50.73 | — |
| Fair | 13x | $69.30 | +37% |
| Expensive | 15x | $80.42 | +59% |
Historical ranges are pointers, not guarantees.
HRB has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
HRB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for HRB, with profitability improving.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
HRB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.12 | +14% |
| Q3 2026 | $5.39 | +23% |
| Q2 2026 | $5.66 | +29% |
| Q1 2026 | $5.54 | +39% |
| Q4 2025 | $4.25 | +20% |
| Q3 2025 | $4.37 | +9.3% |
| Q2 2025 | $4.39 | +6.6% |
| Q1 2025 | $3.98 | -7.7% |
| Q4 2024 | $3.53 | -1.1% |
HRB has the edge over BABA on earnings, with more consistent year-over-year improvement.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over HRB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over HRB on profitability, with a higher operating margin.
HRB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $224.3M | +10% |
| Q2 2026 | $1.1B | +3% |
| Q1 2026 | $2.4B | +5.3% |
| Q4 2025 | $198.9M | +11% |
| Q3 2025 | $203.6M | +5% |
| Q2 2025 | $1.1B | +4.6% |
| Q1 2025 | $2.3B | +4.2% |
| Q4 2024 | $179.1M | 0% |
HRB's revenue has grown year over year for seven quarters in a row: $224M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -103% | -1.7 points |
| Q2 2026 | 33% | -0.5 points |
| Q1 2026 | 43% | +0.3 points |
| Q4 2025 | -150% | +14 points |
| Q3 2025 | -102% | +16 points |
| Q2 2025 | 33% | +0.4 points |
| Q1 2025 | 43% | +0.5 points |
| Q4 2024 | -164% | -15 points |
HRB's operating margin was −103% last quarter, down 1.7 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
HRB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$379.2M | -$9.2M |
| Q2 2026 | $236.5M | -2% |
| Q1 2026 | $1.5B | +18% |
| Q4 2025 | -$649.5M | -$52.1M |
| Q3 2025 | -$370M | -$22.7M |
| Q2 2025 | $241.3M | -17% |
| Q1 2025 | $1.3B | -2.9% |
| Q4 2024 | -$597.4M | +$29.5M |
HRB has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
HRB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.5% | -5.8M shares |
| 1 year | -6.3% | -8.3M shares |
| 3 years | -16% | -23.2M shares |
| 5 years | -31% | -55M shares |
| Available history | -37% | -71M shares |
HRB has the edge over BABA on shareholder dilution, with a more favorable share count trend.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over HRB on leverage, with a lower net debt burden relative to earnings.
HRB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 2.2x | Moderate |
HRB's net debt is about 1.1 years of its operating earnings (EBITDA), down from 1.4 years a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
HRB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.3 | Neutral |
| Stochastic | 63.0 | Neutral |
HRB's weekly RSI is 60 (neutral) and its Stochastic is 63 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
HRB PE vs Consumer Cyclical Sector
| Metric | HRB | Sector median | Relative |
|---|---|---|---|
| PE | 9.4x | 18x | 48% below |
| PE % | 19 | 47 | 28 pts below |
HRB has the edge over BABA on valuation relative to its sector.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
HRB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.6 | 6.5% above |
| 20 week MA | $46.6 | 8.8% above |
| 50 week MA | $40.4 | 26% above |
| 100 week MA | $47.0 | 7.9% above |
| 200 week MA | $46.5 | 9.2% above |
HRB has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
HRB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.4 | $15.5 | -34% |
| 2021 | $15.5 | $23.5 | +52% |
| 2022 | $23.5 | $39.2 | +66% |
| 2023 | $39.2 | $48.4 | +24% |
| 2024 | $48.4 | $53.4 | +10% |
| 2025 | $53.4 | $43.8 | -18% |
| 2026 YTD | $43.8 | $50.7 | +16% |
HRB has the edge over BABA on returns for 2026, with the stronger performance.